Biological Optimization Versus Standard Care in Post-POEM Achalasia Patients (BIO-POEM) (BIO-POEM 1)
Randomized Controlled Trial of Structured Biological Optimization Versus Standard Care With Embedded Prospective Registry in Post-POEM Achalasia Cardia Patients.
This study aims to evaluate whether a structured biological optimization program can improve reflux symptoms and overall recovery in patients with achalasia cardia who previously underwent Peroral Endoscopic Myotomy (POEM). Although POEM is highly effective for relieving swallowing difficulty, many patients develop gastroesophageal reflux disease (GERD) after the procedure and remain dependent on long-term acid suppressive medications such as proton pump inhibitors (PPIs).
The BIO-POEM study will compare structured biological optimization with standard post-POEM care in patients with objectively confirmed pathological reflux after POEM. The intervention includes reflux-oriented dietary counseling, micronutrient assessment and correction, Helicobacter pylori testing and eradication when indicated, lifestyle optimization, and structured review and tapering of PPI/PCAB therapy.
The study includes two components:
A randomized controlled trial enrolling post-POEM patients with objectively confirmed reflux.
A parallel prospective observational registry enrolling symptomatic post-POEM patients who are unable to undergo reflux testing or who remain symptomatic despite low acid exposure.
The primary objective is to determine whether structured biological optimization reduces GERD symptom burden at 12 months compared with standard care. Secondary objectives include evaluation of dyspepsia symptoms, nutritional recovery, quality of life, reduction in PPI dependence, and exploratory assessment of gut microbiome changes.
연구 개요
상세 설명
This study aims to evaluate whether a structured biological optimization program can improve reflux symptoms and overall recovery in patients with achalasia cardia who previously underwent Peroral Endoscopic Myotomy (POEM). Although POEM is highly effective for relieving swallowing difficulty, many patients develop gastroesophageal reflux disease (GERD) after the procedure and remain dependent on long-term acid suppressive medications such as proton pump inhibitors (PPIs).
The BIO-POEM study will compare structured biological optimization with standard post-POEM care in patients with objectively confirmed pathological reflux after POEM. The intervention includes reflux-oriented dietary counseling, micronutrient assessment and correction, Helicobacter pylori testing and eradication when indicated, lifestyle optimization, and structured review and tapering of PPI/PCAB therapy.
The study includes two components:
A randomized controlled trial enrolling post-POEM patients with objectively confirmed reflux.
A parallel prospective observational registry enrolling symptomatic post-POEM patients who are unable to undergo reflux testing or who remain symptomatic despite low acid exposure.
The primary objective is to determine whether structured biological optimization reduces GERD symptom burden at 12 months compared with standard care. Secondary objectives include evaluation of dyspepsia symptoms, nutritional recovery, quality of life, reduction in PPI dependence, and exploratory assessment of gut microbiome changes.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Telangana
-
Hyderabad, Telangana, 인도, 500032
- Asian Institute of Gastroenterology
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria for RCT
- Above criteria plus AET> 6% on pH impedance monitoring.
- Adults aged 18-70 years.
- Patients who stopped PPI/PCABs atleast 4 weeks prior to enrolment (to avoid false negative h.pylori test)
- Prior POEM performed between 6 months and 5 years before enrolment at AIG hospitals.
- Willingness to comply with lifestyle and nutritional interventions.
- Ability to provide written informed consent.
Inclusion Criteria for Observational Registry
- Adults aged 18-70 years.
- Prior POEM performed between 6 months and 5 years before enrolment, at AIG hospitals.
- Clinically significant GERD symptoms after POEM. GERD-HRQL score ≥10, or
- reflux symptoms occurring ≥3 times per week, or
- current use of PPI/PCAB therapy for reflux symptom control
- reflux esophagitis on endoscopy.
- Unable to undergo ambulatory reflux monitoring due to logistical reasons, .
- Ability to provide written informed consent.
Exclusion criteria:
- Prior oesophageal surgery other than POEM.
- Severe comorbidities limiting life expectancy (<2 years).
- Pregnancy or lactation.
- Active gastrointestinal malignancy.
- Contraindication to PPI therapy.
- Inability to provide informed consent or comply with follow-up.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Structured Biological Optimization
Participants in this arm will receive a structured, protocol-driven biological optimization program in addition to standard post-POEM follow-up.
The intervention includes reflux-oriented dietary counseling, lifestyle modification, micronutrient assessment and correction (including vitamin D, B12, iron, calcium, and pre-albumin where deficient), Helicobacter pylori testing and eradication where indicated, and a structured, stepwise de-escalation of proton pump inhibitor (PPI) or potassium-competitive acid blocker (PCAB) therapy based on clinical response and physician assessment.
|
A structured, protocol-driven multimodal intervention designed to optimize post-POEM recovery in patients with achalasia cardia.
The intervention includes individualized reflux-oriented dietary counseling (meal timing, portion control, and trigger food modification), lifestyle optimization (sleep hygiene, weight management, and physical activity guidance), systematic evaluation and correction of micronutrient deficiencies (including vitamin D, vitamin B12, iron, calcium, magnesium, and pre-albumin where indicated), Helicobacter pylori testing with eradication therapy when positive, and a structured, stepwise protocol for proton pump inhibitor (PPI) or potassium-competitive acid blocker (PCAB) de-escalation guided by symptoms and clinical assessment.
The intervention is delivered as a standardized care pathway integrated into routine post-POEM follow-up.
다른 이름들:
|
|
활성 비교기: Standard Post-POEM Care
Participants in this arm will receive routine post-POEM care as practiced at the study center.
Management will be symptom-driven and may include proton pump inhibitor (PPI) or PCAB therapy as clinically indicated.
No structured dietary, micronutrient, or deprescribing protocol will be applied beyond standard clinical practice.
Follow-up assessments and outcome evaluations will be performed in the same manner as the intervention arm.
|
A structured, protocol-driven multimodal intervention designed to optimize post-POEM recovery in patients with achalasia cardia.
The intervention includes individualized reflux-oriented dietary counseling (meal timing, portion control, and trigger food modification), lifestyle optimization (sleep hygiene, weight management, and physical activity guidance), systematic evaluation and correction of micronutrient deficiencies (including vitamin D, vitamin B12, iron, calcium, magnesium, and pre-albumin where indicated), Helicobacter pylori testing with eradication therapy when positive, and a structured, stepwise protocol for proton pump inhibitor (PPI) or potassium-competitive acid blocker (PCAB) de-escalation guided by symptoms and clinical assessment.
The intervention is delivered as a standardized care pathway integrated into routine post-POEM follow-up.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL) Score From Baseline to 12 Months
기간: Baseline and 12 months
|
The primary outcome is the change in Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL) score from baseline to 12 months after randomization in post-POEM patients with objectively confirmed pathological reflux. The GERD-HRQL questionnaire is a validated reflux-specific symptom assessment scale with total scores ranging from 0 to 50, where higher scores indicate worse reflux symptoms and poorer reflux-related quality of life. |
Baseline and 12 months
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Proportion of Participants Successfully Discontinuing Proton Pump Inhibitor (PPI) or Potassium-Competitive Acid Blocker (PCAB) Therapy by 12 Months
기간: 6 months and 12 months
|
Proportion of participants successfully discontinuing proton pump inhibitor (PPI) or potassium-competitive acid blocker (PCAB) therapy by 12 months after initiation of study intervention.
|
6 months and 12 months
|
|
Change in Leeds Dyspepsia Questionnaire Score From Baseline to 6 and 12 Months
기간: Baseline, 6 months, and 12 months
|
Change in dyspepsia symptom severity assessed using the Leeds Dyspepsia Questionnaire. Higher scores indicate worse dyspepsia symptoms. |
Baseline, 6 months, and 12 months
|
|
Change in Serum Vitamin D Levels From Baseline to 6 Months
기간: Baseline and 6 months
|
Change in serum vitamin D levels measured in ng/mL.
|
Baseline and 6 months
|
|
Change in Serum Calcium Levels
기간: Baseline and 6 months
|
Change in serum calcium levels measured in mg/dL.
|
Baseline and 6 months
|
|
Change in Serum Iron Levels
기간: Baseline and 6 months
|
Change in serum iron levels measured in µg/dL.
|
Baseline and 6 months
|
|
Change in Serum Vitamin B12 Levels
기간: Baseline and 6 months
|
Change in serum vitamin B12 levels measured in pg/mL.
|
Baseline and 6 months
|
|
Change in Serum Pre-albumin Levels
기간: Baseline and 6 months
|
Change in serum pre-albumin levels measured in mg/dL.
|
Baseline and 6 months
|
|
Change in SF-36 Quality of Life Scores From Baseline to 6 and 12 Months
기간: Baseline, 6 months, and 12 months
|
Change in health-related quality of life assessed using the 36-Item Short Form Survey (SF-36). SF-36 scores range from 0 to 100, with higher scores indicating better quality of life. |
Baseline, 6 months, and 12 months
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Mohan Kumar Ramchandani, MD,DM, Asian Institute of Gastroenterology
간행물 및 유용한 링크
일반 간행물
- Singh AP, Singla N, Budhwani E, Januszewicz W, Memon SF, Inavolu P, Nabi Z, Jagtap N, Kalapala R, Lakhtakia S, Darisetty S, Reddy DN, Ramchandani M. Defining "true acid reflux" after peroral endoscopic myotomy for achalasia: a prospective cohort study. Gastrointest Endosc. 2024 Feb;99(2):166-173.e3. doi: 10.1016/j.gie.2023.08.008. Epub 2023 Aug 19.
- Nabi Z, Inavolu P, Duvvuru NR. Prediction, prevention and management of gastroesophageal reflux after per-oral endoscopic myotomy: An update. World J Gastroenterol. 2024 Mar 7;30(9):1096-1107. doi: 10.3748/wjg.v30.i9.1096.
- Samarasam I, Joel RK, Pulimood AB. Gastroesophageal reflux following per-oral endoscopic myotomy: Can we improve outcomes? World J Gastroenterol. 2024 Jun 14;30(22):2834-2838. doi: 10.3748/wjg.v30.i22.2834.
- Nabi Z, Basha J, Inavolu P, Goud R, Veligatla V, Tummuru SP, Cheripelli N, Arutla M, Ramchandani M, Darisetty S, Nageshwar Reddy D. Comprehensive analysis of nutritional parameters in patients with idiopathic achalasia: A prospective study in India. Indian J Gastroenterol. 2025 Feb;44(1):57-63. doi: 10.1007/s12664-024-01664-5. Epub 2024 Aug 19.
- Hazrah P. Reflux after peroral endoscopic myotomy: The dilemma and the options. World J Gastroenterol. 2025 Feb 14;31(6):100510. doi: 10.3748/wjg.v31.i6.100510.
- Bapaye A, Yewale R, Shah J, Bale R A, Ansari J, Borkar M, Bapaye H, Pujari R, Gadhikar H. Long-term (3-year) composite gastroesophageal reflux outcomes of peroral endoscopic myotomy with or without concomitant endoscopic fundoplication in matched cohorts of achalasia. Gastrointest Endosc. 2026 Feb;103(2):241-252. doi: 10.1016/j.gie.2025.04.029. Epub 2025 Apr 25.
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .